LITALGIN

This brand name is authorized in Estonia, Finland

Active ingredients

The drug LITALGIN contains a combination of these active pharmaceutical ingredients (APIs):

1 Metamizole sodium
UNII VSU62Z74ON - METAMIZOLE SODIUM

Metamizole sodium is a pyrazolone derivative with analgesic, antipyretic and slight antiinflammatory and spasmolytic properties. It has the most potent analgesic effect of all the pyrazolone derivatives. As with other analgesics, its mechanism of action has not been elucidated in detail. It includes inhibition of prostaglandin synthesis (PGE1 and PGE2) and reversible inhibition of platelet aggregation. It inhibits cyclo-oxygenase and influences the effect of arachidonic acid.

Read about Metamizole sodium
2 Pitofenone
UNII HE1ZA4ZBEX - PITOFENONE HYDROCHLORIDE
Read about Pitofenone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
A03DA02 Pitofenone and analgesics A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03D Antispasmodics in combination with analgesics → A03DA Synthetic anticholinergic agents in combination with analgesics
Discover more medicines within A03DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1886047
Country: FI Lรครคkealan turvallisuus- ja kehittรคmiskeskus Identifier(s): 044533, 476127, 492165

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.